Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing the proprietary RNA interference platform.

Biotechnology

Education

Atalanta Therapeutics

Alicia Secor

Mark Murphy

Antonio N.

Matthew Grear

Serena Hung

Jim Glasheen

Jeff Young

Craig Mello

Anastasia Khvorova

Brittany Ferdman

Morgan Molloy

Maurice Smith

Guillermo Yudowski

Bart G. Newland

Michele Keough

Stephen Burke

Aimee L. Jackson

Scientific Research Team

Scientific and Technical Advisory

Leadership Team

Operations Team

Research and Development

Teams at Atalanta Therapeutics

Scientific Research Team

Scientific and Technical Advisory

Leadership Team

Operations Team

Research and Development